Latest News | Ipca Labs Q2 Profit Up 58 Pc to Rs 229 Cr
Get latest articles and stories on Latest News at LatestLY. Ipca Laboratories on Thursday said its consolidated net profit declined 58 per cent year-on-year to Rs 229 crore in the September quarter.
New Delhi, Nov 14 (PTI) Ipca Laboratories on Thursday said its consolidated net profit declined 58 per cent year-on-year to Rs 229 crore in the September quarter.
The drug firm had reported a net profit of Rs 145 crore in the year-ago period.
Revenue from operations rose to Rs 2,355 crore for the second quarter of the current fiscal year as compared with Rs 2,034 crore in the year-ago period, Ipca Laboratories said in a regulatory filing.
The company said its domestic formulations business revenue stood at Rs 940 crore for the quarter, up 11 per cent from Rs 845 crore a year earlier.
Also Read | Janjatiya Gaurav Divas 2024: Celebrating Tribal Heritage on Bhagwan Birsa Munda Jayanti.
Export of generics stood at Rs 286 crore in the July-September period as against Rs 264 crore, registering a year-on-year growth of 8 per cent.
The company said its board has approved an interim dividend of Rs 21 per share of Re 1 each for 2024-25.
Shares of the company on Thursday ended 2.02 per cent up at Rs 1,538.65 apiece on the BSE.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)